about
Anti-inflammatory effects of flavonoids [etc.]Urate crystal induced inflammation and joint pain are reduced in transient receptor potential ankyrin 1 deficient mice--potential role for transient receptor potential ankyrin 1 in goutAdipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease.YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic jointsBreast milk fatty acids, eicosanoids, and cytokines in mothers with and without allergic disease.Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis.Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1.The Inflammatory Phenotype in Failed Metal-On-Metal Hip Arthroplasty Correlates with Blood Metal Concentrations.Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort StudyAttenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1.Transient receptor potential ankyrin 1 (TRPA1) is functionally expressed in primary human osteoarthritic chondrocytes.Dexamethasone-eluting vascular stents.Anti-inflammatory Effects of Nortrachelogenin in Murine J774 Macrophages and in Carrageenan-Induced Paw Edema Model in the Mouse.Increased plasma UCH-L1 after aneurysmal subarachnoid hemorrhage is associated with unfavorable neurological outcome.Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 expressions in activated macrophages.Effects of levo- and dextrosimendan on NF-kappaB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli.Calcineurin inhibitors down-regulate iNOS expression by destabilizing mRNA.Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to infInhibition of iNOS expression and NO production by anti-inflammatory steroids. Reversal by histone deacetylase inhibitors.Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines.Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes.Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects.Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Is Not Associated with Neurological Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage.Confined ischemia may improve remote myocardial outcome after rat cardiac arrest.Dexamethasone inhibits inducible nitric-oxide synthase expression and nitric oxide production by destabilizing mRNA in lipopolysaccharide-treated macrophages.Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage. Role of endogenous IL-1 inhibitors.Regulation of eosinophil apoptosis by nitric oxide: Role of c-Jun-N-terminal kinase and signal transducer and activator of transcription 5.Phenolic extractives from the bark of Pinus sylvestris L. and their effects on inflammatory mediators nitric oxide and prostaglandin E2.Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine.Nitric oxide-releasing compounds inhibit the production of interleukin-2, -4 and -10 in activated human lymphocytes.Preclinical evaluation of rapeseed, raspberry, and pine bark phenolics for health related effects.Inhibition of monoamine oxidase A increases recovery after experimental cardiac arrest.Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage.INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine.Adipokines played a limited role in predicting temporary growth differences between very low birthweight infants with and without bronchopulmonary dysplasia.Resistin and interleukin 6 as predictive factors for recurrence and long-term prognosis in renal cell cancer.High YKL-40 is associated with poor survival in patients with renal cell carcinoma: a novel independent prognostic marker.Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine.Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.
P50
Q21342966-513170E2-5AF4-4CCF-B1D2-06E4DFEFC678Q28543261-D0EA3EFB-7AF7-4F5D-874D-2965C4A79AAEQ33660762-FDA0081B-C404-447E-83BE-A454902DC73FQ34012380-24B51CC5-582A-43AB-A92F-E05D6EFA2C0CQ34531750-3D1A750C-D5BB-48E8-B518-517079CE0BB9Q35768186-3AF570FA-E495-458E-8878-4DE81A6B1CE7Q35915798-126CF990-9DBB-4C8B-A84E-9A0D07C29944Q36030146-9CE7BDC7-9035-4F52-8830-443EF806C32DQ36113242-993522B8-74A4-4B75-A050-0AEE4D1197C4Q37046760-13F5E13E-B651-4357-B24D-08F23F87CDC6Q37169416-30B8F865-C4F4-4727-8B88-1998748C4E28Q38078557-79D98885-DD84-4050-891D-0D8655D8F55FQ38741310-9A520D19-92FB-4DD6-9946-4B7119D5107EQ38916137-F94EAD02-8E2C-48B2-A9D2-8F3C60981D65Q39588155-D321CD35-7F21-4758-AEF6-E681E640BB96Q39918710-2CA3CDE4-8725-4A9C-8901-3A284FCDEB8CQ39951944-F882E756-D0BD-40A6-B915-265C7627D594Q40044297-1ABF3837-08EC-4D04-A98B-B2052710C5EAQ40072631-ECF75F67-D138-4502-9E89-797C00B1A64CQ40715072-E7085C7D-D664-45AC-B879-D972A75CBEC8Q41919879-027DB940-94C8-47F7-87CF-BB880611031AQ42241520-F88E7108-E334-4939-9CC7-3580B93F58F3Q42291229-8341A3F5-4EB4-4622-ACA5-5B27D7191E43Q44047612-A7BF9756-0C33-4164-B80E-B1F676EF7AF8Q44104298-BB479ACD-F546-4085-8A1F-62DC0AB7E366Q44361092-601A22BF-AF8C-4EC0-BC90-108C350BC540Q44504332-1B9E81DA-8A6E-4A89-97DC-CDB9C8997896Q45241379-01EB55C8-E59B-4537-AC90-CF260ED9AE80Q45372399-6FE171E0-48D3-42BA-BE6B-50BA72A82E58Q46442820-B995073E-6DE8-41B1-AD09-BD545EDCA707Q46608152-CD3AC53F-E760-4AF2-84BE-FE867EA600ACQ46708944-089EB87F-808B-43CD-9602-72EB1B3B04A1Q47131419-C6F03EE9-B2B6-403C-BF52-84F9962DCA83Q47255631-3C056BB3-9827-480A-B9B1-24FB7DDF7469Q47339520-DF3CE663-3B6E-46DB-96E8-C4E6E29C36D7Q47358338-012153F1-8653-406C-8AD1-F5786A303A90Q47810204-F3E4B514-660F-4D22-B6B7-B3531576B845Q47880725-84A6D504-5D01-4232-AB3C-638A620EACB7Q47931115-FAF1130B-6C52-4FF4-AFC7-B75EE448EB34Q48032551-536D1091-0EE9-4B1C-A033-98170E07515E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mari Hämäläinen
@ast
Mari Hämäläinen
@en
Mari Hämäläinen
@es
Mari Hämäläinen
@nl
Mari Hämäläinen
@sl
type
label
Mari Hämäläinen
@ast
Mari Hämäläinen
@en
Mari Hämäläinen
@es
Mari Hämäläinen
@nl
Mari Hämäläinen
@sl
prefLabel
Mari Hämäläinen
@ast
Mari Hämäläinen
@en
Mari Hämäläinen
@es
Mari Hämäläinen
@nl
Mari Hämäläinen
@sl
P106
P1153
7102722254
P31
P496
0000-0002-6409-3758